Published on 23 Nov 2021 on SmarterAnalyst
Enanta Pharmaceuticals, Inc. (ENTA) has reported mixed results for the fourth quarter of Fiscal Year 2021 (ended September 30, 2021). The biotechnology
Start tracking your investments with Statfolio
Cerence Inc (NASDAQ:CRNC), a company specializing in creating unique, moving experiences for the ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cerence fair value estimate is US$27.11C...
Cerence Inc. (NASDAQ:CRNC) Q1 2024 Earnings Call Transcript February 6, 2024 Cerence Inc. misses ...
Stefan Ortmanns, CEO of Cerence Inc (NASDAQ:CRNC), executed a sale of 11,942 shares in the compan...
Cerence CRNC is benefiting from an expanding clientele and enhancing its global footprint in the ...
Cerence CRNC is benefiting from an expanding clientele and strong partner base with its recent co...
Cerence CRNC recently launched its automotive specific large language model, Cerence Automotive L...
Cerence Inc. CRNC reported non-GAAP earnings of 9 cents per share in fourth-quarter fiscal 2023, ...
Stocks that are trading heavily or have substantial price changes on Monday: Cerence, Roivant...
(Bloomberg) -- A five-month rally in MediaTek Inc. looks set to extend as booming demand for smar...